Delayed Graft Function in the Kidney Transplant
暂无分享,去创建一个
[1] R. Ploeg,et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. , 2009, The New England journal of medicine.
[2] G. Gomes,et al. TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720. , 2011, International immunopharmacology.
[3] Anthony J. Muslin,et al. RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury. , 2011, Kidney international.
[4] T. Minor,et al. Single-Center Experience With Kidney Transplantation Using Deceased Donors Older Than 75 Years , 2011, Transplantation.
[5] G. Klintmalm,et al. YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: a double‐blind, placebo‐controlled, multi‐center Phase IIa study 1,2,3 , 2011, Clinical transplantation.
[6] B. Winkens,et al. Kidney Transplantation from Donors after Cardiac Death: Uncontrolled versus Controlled Donation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] H. van Goor,et al. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] Jean‐Paul Squifflet,et al. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[9] P. Reese,et al. Recipient Risk Factors Associated With Delayed Graft Function: A Paired Kidney Analysis , 2011, Transplantation.
[10] D. Goldfarb. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. , 2011, The Journal of urology.
[11] F. Schena,et al. T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[12] A. Layton,et al. A mathematical model of the myogenic response to systolic pressure in the afferent arteriole. , 2011, American journal of physiology. Renal physiology.
[13] J. Vella,et al. Hypertension after kidney transplant. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] K. Hruska,et al. RGS4 Prevents the Development of Renal Dysfunction in Response to Ischemia/Reperfusion Injury , 2011 .
[15] B. Banas,et al. A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. , 2010, Clinical science.
[16] E. Hajizadeh,et al. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction. , 2010, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
[17] M. Christiaans,et al. Kidney Transplantation From Donors After Cardiac Death: A 25-Year Experience , 2010, Transplantation.
[18] A. Pascher,et al. Novel Markers in Zero-Hour Kidney Biopsies Indicate Graft Quality and Clinical Outcome , 2010, Transplantation.
[19] J. Pratschke,et al. Role of heme oxygenase‐1 in transplantation , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[20] D. Kuypers,et al. A prospective, open-label, observational clinical cohort study of the association between delayed renal allograft function, tacrolimus exposure, and CYP3A5 genotype in adult recipients. , 2010, Clinical therapeutics.
[21] A Buscaroli,et al. The influence of intraoperative central venous pressure on delayed graft function in renal transplantation: a single-center experience. , 2010, Transplantation proceedings.
[22] L. Domański,et al. Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function. , 2010, Journal of the American College of Surgeons.
[23] L. Otterbein,et al. Intraoperative Administration of Inhaled Carbon Monoxide Reduces Delayed Graft Function in Kidney Allografts in Swine , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[24] Jean-Paul Squifflet,et al. Machine Perfusion Versus Cold Storage for the Preservation of Kidneys Donated After Cardiac Death: A Multicenter, Randomized, Controlled Trial , 2010, Annals of surgery.
[25] Rachel J. Johnson,et al. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study , 2010, The Lancet.
[26] P. Ponikowski,et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. , 2010, The New England journal of medicine.
[27] T. V. van Veen,et al. Selective deletion of Connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension. , 2010, Kidney international.
[28] O. Celhay,et al. Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular Atrophy , 2010, Transplantation.
[29] W. Irish,et al. Cold Machine Perfusion or Static Cold Storage of Kidneys: Why the Debate Continues , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[30] K. Safranow,et al. The association between eNOS intron 4 VNTR polymorphism and delayed graft function of kidney allografts , 2010, Clinical transplantation.
[31] J. Bradley,et al. Cold Machine Perfusion Versus Static Cold Storage of Kidneys Donated After Cardiac Death: A UK Multicenter Randomized Controlled Trial , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[32] M. Souter,et al. Ethical controversies at end of life after traumatic brain injury: defining death and organ donation. , 2010, Critical care medicine.
[33] Jeremiah R. Brown,et al. Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[34] José A Fernández,et al. Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. , 2010, The Journal of clinical investigation.
[35] J. Iacomini,et al. Identification of a microRNA signature of renal ischemia reperfusion injury , 2010, Proceedings of the National Academy of Sciences.
[36] L. Rostaing,et al. High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[37] P. Zhou,et al. Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis. , 2010, Transplantation proceedings.
[38] R. Bartlett,et al. Extracorporeal Support: Improves Donor Renal Graft Function After Cardiac Death , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] T. Minor,et al. Hypothermic reconditioning after cold storage improves postischemic graft function in isolated porcine kidneys , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[40] M. Okusa,et al. Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. , 2010, Seminars in nephrology.
[41] A. Ismael,et al. The Impact of Timing of Maximal Crystalloid Hydration on Early Graft Function During Kidney Transplantation , 2010, Anesthesia and analgesia.
[42] R. Colvin,et al. Tubular expression of KIM-1 does not predict delayed function after transplantation. , 2010, Journal of the American Society of Nephrology : JASN.
[43] S. Feng,et al. Diabetes Mellitus: A Risk Factor for Delayed Graft Function after Deceased Donor Kidney Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[44] J. Anderson,et al. RGS4 Controls Renal Blood Flow and Inhibits Cyclosporine‐Mediated Nephrotoxicity , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[45] N. Gretz,et al. A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage. , 2010, Molecular immunology.
[46] R. Goldschmeding,et al. Histological assessment of pre‐transplant kidney biopsies is reproducible and representative , 2010, Histopathology.
[47] L. Lerman,et al. Anti‐thrombin Therapy During Warm Ischemia and Cold Preservation Prevents Chronic Kidney Graft Fibrosis in a DCD Model , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[48] T. Pruett. Effects of Donor Pretreatment With Dopamine on Graft Function After Kidney Transplantation: A Randomized Controlled Trial , 2010 .
[49] C. Cardella,et al. Delayed graft function and the risk for death with a functioning graft. , 2010, Journal of the American Society of Nephrology : JASN.
[50] C. Parikh,et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.
[51] Gerhard Opelz,et al. C3 polymorphisms and allograft outcome in renal transplantation. , 2009, The New England journal of medicine.
[52] W. Winkelmayer,et al. Effect of Hemodialysis Before Transplant Surgery on Renal Allograft Function—A Pair of Randomized Controlled Trials , 2009, Transplantation.
[53] K. Budde,et al. A Randomized Trial Comparing Renal Function in Older Kidney Transplant Patients Following Delayed Versus Immediate Tacrolimus Administration , 2009, Transplantation.
[54] S. Ricardo,et al. Renal primary cilia lengthen after acute tubular necrosis. , 2009, Journal of the American Society of Nephrology : JASN.
[55] J. Czerwiński,et al. Complications of transplantation of kidneys from expanded-criteria donors. , 2009, Transplantation proceedings.
[56] N. Gretz,et al. Wnt Pathway Regulation in Chronic Renal Allograft Damage , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[57] R. Stratta,et al. A Randomized Trial of Alemtuzumab Versus Antithymocyte Globulin Induction in Renal and Pancreas Transplantation , 2009, Transplantation.
[58] A. Borobia,et al. Trough Tacrolimus Concentrations in the First Week After Kidney Transplantation Are Related to Acute Rejection , 2009, Therapeutic drug monitoring.
[59] P. Halloran,et al. Diagnosing Rejection in Renal Transplants: A Comparison of Molecular‐ and Histopathology‐Based Approaches , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[60] F. Thévenod,et al. Iron transport and the kidney. , 2009, Biochimica et biophysica acta.
[61] H. Rabb,et al. The interaction between ischemia–reperfusion and immune responses in the kidney , 2009, Journal of Molecular Medicine.
[62] A. Israni,et al. Similar Outcomes with Different Rates of Delayed Graft Function May Reflect Center Practice, Not Center Performance , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[63] J. Squifflet,et al. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. , 2009, Journal of the American Society of Nephrology : JASN.
[64] L. Wrenshall,et al. Increased Primary Non‐Function in Transplanted Deceased‐Donor Kidneys Flushed with Histidine‐Tryptophan‐Ketoglutarate Solution , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[65] U. Völker,et al. Multidrug resistance-related protein 2 genotype of the donor affects kidney graft function , 2009, Pharmacogenetics and genomics.
[66] Youhua Liu,et al. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. , 2009, Journal of the American Society of Nephrology : JASN.
[67] R. Formica,et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[68] M. Givertz,et al. Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure. , 2009, Expert opinion on pharmacotherapy.
[69] M. Stegall,et al. Pulmonary Hypertension Is Associated With Reduced Patient Survival After Kidney Transplantation , 2008, Transplantation.
[70] A. Salim,et al. Aggressive Organ Donor Management Protocol , 2008, Journal of intensive care medicine.
[71] M. Christiaans,et al. Histological Assessment of Preimplantation Biopsies May Improve Selection of Kidneys from Old Donors After Cardiac Death , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[72] A. Garg,et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[73] A. Israni,et al. Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[74] J. Gaynor,et al. Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/Thymoglobulin: One Year Follow-Up , 2008, Transplantation.
[75] S. Knechtle,et al. Calcineurin Inhibitor Withdrawal After Renal Transplantation with Alemtuzumab: Clinical Outcomes and Effect on T‐Regulatory Cells , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[76] J Concato,et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. , 2008, Kidney international.
[77] V. Haase,et al. Low oxygen stimulates the immune system. , 2008, Kidney international.
[78] M. Hensel,et al. Hypoxia and Hypoxia-Inducible Factor-1α Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function1 , 2008, The Journal of Immunology.
[79] K. Salmela,et al. Intragraft Coagulation Events and Delayed Graft Function in Clinical Renal Transplantation , 2008, Transplantation.
[80] Joseph A. Cruz,et al. The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[81] J. Gaynor,et al. A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow‐up , 2007, Clinical transplantation.
[82] B. Gerstmayer,et al. Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. , 2007, Antioxidants & redox signaling.
[83] M. Żukowski,et al. Influence of selected factors on occurrence of delayed kidney graft function: a multivariate analysis. , 2007, Transplantation proceedings.
[84] P. Heeger,et al. Graft-derived complement as a mediator of transplant injury. , 2007, Current opinion in immunology.
[85] S. Chadban,et al. TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.
[86] E. Porrini,et al. Randomized Controlled Study Comparing Reduced Calcineurin Inhibitors Exposure Versus Standard Cyclosporine-Based Immunosuppression , 2007, Transplantation.
[87] A. Khanafer,et al. Increased Nitric Oxide Production During Acute Rejection in Kidney Transplantation: A Useful Marker to Aid in the Diagnosis of Rejection , 2007, Transplantation.
[88] G. Russ,et al. Trends in Kidney Transplantation in Australia and New Zealand, 1993–2004 , 2007, Transplantation.
[89] Claude D Martin,et al. Impact of intensive care on renal function before graft harvest: results of a monocentric study , 2007, Critical care.
[90] R. Bertini,et al. Protective effect of an inhibitor of interleukin-8 (meraxin) from ischemia and reperfusion injury in a rat model of kidney transplantation. , 2007, Transplantation proceedings.
[91] D. Villers,et al. Effect of Brain-Dead Donor Resuscitation on Delayed Graft Function: Results of a Monocentric Analysis , 2007, Transplantation.
[92] U. Hopt,et al. Evaluation of preservation solutions by ESR-spectroscopy: superior effects of University of Wisconsin over Histidine-Tryptophan-Ketoglutarate in reducing renal reactive oxygen species. , 2007, Kidney international.
[93] W. Buurman,et al. Recipient Hemodynamics During Non‐Heart‐Beating Donor Kidney Transplantation Are Major Predictors of Primary Nonfunction , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[94] K. Nath,et al. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. , 2007, Kidney international.
[95] R. Quigg,et al. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. , 2007, Journal of the American Society of Nephrology : JASN.
[96] T. Ganz. Molecular control of iron transport. , 2007, Journal of the American Society of Nephrology : JASN.
[97] B. Jaber,et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. , 2007, Journal of the American Society of Nephrology : JASN.
[98] D. Brennan,et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. , 2006, The New England journal of medicine.
[99] D. Pittrow,et al. Role of endothelin and endothelin receptor antagonists in renal disease , 2006, European journal of clinical investigation.
[100] R. Fisher,et al. Molecular markers in stored kidneys using perfluorocarbon-based preservation solution: preliminary results. , 2006, Transplantation proceedings.
[101] P. Devarajan. Update on mechanisms of ischemic acute kidney injury. , 2006, Journal of the American Society of Nephrology : JASN.
[102] R. Vaughan,et al. Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.
[103] L. Rostaing,et al. Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[104] A. Agarwal,et al. Comparison of Histidine-Tryptophan Ketoglutarate Solution and University of Wisconsin Solution in Prolonged Cold Preservation of Kidney Allografts , 2006, Transplantation.
[105] W. van Biesen,et al. The impact of the pre-transplant renal replacement modality on outcome after cadaveric kidney transplantation: the ghent experience. , 2006, Contributions to nephrology.
[106] P. Macdonald,et al. Organ preservation. , 2006, Methods in molecular biology.
[107] M. Stegall,et al. Improving the Prediction of Donor Kidney Quality: Deceased Donor Score and Resistive Indices , 2005, Transplantation.
[108] T. Minor,et al. Oxygenated machine perfusion preservation of predamaged kidneys with HTK and Belzer machine perfusion solution: an experimental study in pigs. , 2005, Transplantation Proceedings.
[109] D. Machin,et al. Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1 , 2005, Transplantation.
[110] J. Gaynor,et al. A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1 , 2005, Transplantation.
[111] Daniel C. Brennan,et al. A Randomized, Prospective, Pharmacoeconomic Trial of Tacrolimus versus Cyclosporine in Combination with Thymoglobulin in Renal Transplant Recipients , 2005, Transplantation.
[112] Po-Huang Lee,et al. Expanding the donor pool: use of renal transplants from non‐heart‐beating donors supported with extracorporeal membrane oxygenation , 2005, Clinical transplantation.
[113] G. Remuzzi,et al. Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. , 2005, Kidney international.
[114] A. Kandus,et al. Prevention of Early Acute Rejection With Daclizumab and Triple Immunosuppression in Cadaveric Renal Allograft Recipients , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[115] R. Bartlett,et al. Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. , 2004, The Journal of trauma.
[116] B. Korf,et al. PERFUSION PARAMETERS IN PREDICTING OUTCOMES OF MACHINE PRESERVED KIDNEYS , 2004 .
[117] K. Voigt,et al. Hemodynamic responses to noxious stimuli in brain-dead organ donors , 2005, Intensive Care Medicine.
[118] R. Vanholder,et al. Delayed graft function in renal transplantation , 2004, Current opinion in critical care.
[119] D. Stolz,et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. , 2004, American journal of physiology. Renal physiology.
[120] K. Budde,et al. Calcium Channel Blockade and Preservation of Renal Graft Function in Cyclosporine-Treated Recipients: A Prospective Randomized Placebo-Controlled 2-Year Study , 2004, Transplantation.
[121] Y. Becker,et al. Campath-1H in renal transplantation: The University of Wisconsin experience. , 2004, Surgery.
[122] M. Schnitzler,et al. Five-Year Follow Up of Thymoglobulin Versus ATGAM Induction in Adult Renal Transplantation , 2004, Transplantation.
[123] C. Szabó,et al. Poly(ADP-ribose) polymerase and renal hypothermic preservation injury. , 2004, American journal of physiology. Renal physiology.
[124] H. Anders,et al. Signaling danger: toll-like receptors and their potential roles in kidney disease. , 2004, Journal of the American Society of Nephrology : JASN.
[125] B. Aizenstein,et al. Elevation of CXCR3‐Binding Chemokines in Urine Indicates Acute Renal‐Allograft Dysfunction , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[126] S. Post,et al. Impact of Donor Dopamine on Immediate Graft Function after Kidney Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[127] A. Yim,et al. Histidine-tryptophan-ketoglutarate solution maximally preserves endothelium-derived hyperpolarizing factor-mediated function during heart preservation: comparison with University of Wisconsin solution. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[128] J. Punch,et al. Kidney transplantation from organ donors following cardiopulmonary death using extracorporeal membrane oxygenation support. , 2004, Annals of transplantation.
[129] M. Radomski,et al. The Nitric Oxide-Endothelin-1 Connection , 2004, Heart Failure Reviews.
[130] V. Papadopoulos,et al. Evidence for a protective role of trimetazidine during cold ischemia: targeting inflammation and nephron mass. , 2003, Biochemical pharmacology.
[131] G. Molema,et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. , 2003, Kidney international.
[132] K. Matsushima,et al. J Am Soc Nephrol 14: 2503–2515, 2003 CCR2 Signaling Contributes to Ischemia-Reperfusion Injury , 2022 .
[133] J. Chilcott,et al. Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review , 2003, Clinical transplantation.
[134] M. Sarwal,et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. , 2003, The New England journal of medicine.
[135] J. Antonelli,et al. Endothelin-receptor blockade mitigates the adverse effect of preretrieval warm ischemia on posttransplantation renal function in rats1 , 2003, Transplantation.
[136] N. Patel,et al. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. , 2003, Kidney international.
[137] F. Delmonico,et al. Aggressive pharmacologic donor management results in more transplanted organs1 , 2003, Transplantation.
[138] F. Delmonico,et al. A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients , 2003 .
[139] Christopher P. Johnson,et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. , 2002, Kidney international.
[140] R. Loutzenhiser,et al. Renal Myogenic Response: Kinetic Attributes and Physiological Role , 2002, Circulation research.
[141] S. Sacks,et al. Local synthesis of complement component C3 regulates acute renal transplant rejection , 2002, Nature Medicine.
[142] P. Friend,et al. Liver and kidney preservation by perfusion , 2002, The Lancet.
[143] J. Alexander,et al. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. , 2002, American journal of physiology. Renal physiology.
[144] H. Meier‐Kriesche,et al. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. , 2002, Transplantation.
[145] O. Toupance,et al. Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF‐containing Triple Therapy , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[146] M. Pescovitz,et al. BASILIXIMAB VERSUS ANTITHYMOCYTE GLOBULIN FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1,2 , 2001, Transplantation.
[147] D. Shoskes,et al. Delayed graft function: Influence on outcome and strategies for prevention , 2001 .
[148] J. Squifflet,et al. INDUCTION VERSUS NONINDUCTION IN RENAL TRANSPLANT RECIPIENTS WITH TACROLIMUS-BASED IMMUNOSUPPRESSION1 , 2001, Transplantation.
[149] M. Pescovitz,et al. Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. , 2001, Transplantation.
[150] T. Larson,et al. Donor Scoring System for Cadaveric Renal Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[151] J. Lácha,et al. Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients. , 2001, Transplantation proceedings.
[152] H. Rabb,et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. , 2000, American journal of physiology. Renal physiology.
[153] H. Iwamoto,et al. Prediction of kidney nonfunction after transplantation with machine perfusion preservation. , 2000, Transplantation proceedings.
[154] K. Kubota,et al. A useful predictor in machine perfusion preservation for kidney transplantation from non-heart-beating donors. , 2000, Transplantation proceedings.
[155] K. Ley,et al. Blocking P‐selectin protects from ischemia/reperfusion‐induced acute renal failure , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[156] A. Novick,et al. A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplants. , 1999, Transplantation.
[157] I. Doxiadis,et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins , 1999, Transplant international : official journal of the European Society for Organ Transplantation.
[158] S. Fuggle,et al. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. , 1999, Kidney international.
[159] D. Jeyarajah,et al. Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? , 1999, Kidney international.
[160] J Karpinski,et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. , 1999, Transplantation.
[161] M. Schnitzler,et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. , 1999, Transplantation.
[162] E. Condom,et al. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[163] K. Salmela,et al. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. , 1999, Transplantation.
[164] W. Jassem,et al. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long‐term survival in cadaveric renal transplantation , 1999, Clinical transplantation.
[165] B. Maes,et al. Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. , 1998, Transplantation.
[166] D. Shoskes,et al. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. , 1998 .
[167] S. Fuggle,et al. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. , 1998, The American journal of pathology.
[168] D. Pinsky,et al. Hypoxia-mediated modulation of vascular function--implications for organ preservation and thrombogenesis: Roger S. Mitchell lecture. , 1998, Chest.
[169] F. Vermassen,et al. Pretransplantation hemodialysis strategy influences early renal graft function. , 1998, Journal of the American Society of Nephrology : JASN.
[170] J Neylan,et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. , 1998, The New England journal of medicine.
[171] A. Matas,et al. Effect of initial slow graft function on renal allograft rejection and survival. , 1997, Clinical transplantation.
[172] J. H. van Bockel,et al. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. , 1997, Transplantation.
[173] R. Wolfe,et al. Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.
[174] D. Shoskes,et al. Effect of delayed graft function on short- and long-term kidney graft survival. , 1997, Clinical transplants.
[175] D. Klassen,et al. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience. , 1996, Clinical transplantation.
[176] P. Halloran,et al. Delayed graft function in renal transplantation: etiology, management and long-term significance. , 1996, The Journal of urology.
[177] H. Friess,et al. Pathogenesis of delayed kidney graft function: role of endothelin-1, thromboxane B2, and leukotriene B4. , 1996, Transplantation proceedings.
[178] P. Halloran,et al. Acute Renal Injury In The Interferon-γ Gene Knockout Mouse: Effect On Cytokine Gene Expression1 , 1995 .
[179] P. Halloran,et al. Acute renal injury in the interferon-gamma gene knockout mouse: effect on cytokine gene expression. , 1995, Transplantation.
[180] R. Hetzer,et al. Myocardial preservation using HTK solution for heart transplantation. A multicenter study. , 1993, European Journal of Cardio-Thoracic Surgery.
[181] A. Hendrich,et al. Changes in serum catecholamine levels in patients who are brain dead. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[182] U. Kunzendorf,et al. Protective effects of calcium antagonists in human renal transplantation. , 1992, Kidney international. Supplement.
[183] J. Robinette,et al. Differences in vascular reactivity in models of ischemic acute renal failure. , 1991, Kidney international.
[184] R. Miller,et al. Effect of recovery from ischemic injury on class I and class II MHC antigen expression. , 1990, Transplantation.
[185] W. Raub. From the National Institutes of Health. , 1990, JAMA.
[186] P. Halloran,et al. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. , 1990, Transplantation.
[187] M. Giral,et al. Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin. , 1989, Transplantation proceedings.
[188] V. Farewell,et al. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. , 1989, Transplantation.
[189] R. Ploeg,et al. SUCCESSFUL 72‐HOUR COLD STORAGE OF DOG KIDNEYS WITH UW SOLUTION , 1988, Transplantation.
[190] J H Southard,et al. Principles of solid-organ preservation by cold storage. , 1988, Transplantation.
[191] W. Waltzer,et al. The pathophysiology of the no-reflow phenomenon in cold-stored kidneys. , 1987, Transplantation proceedings.
[192] J H Southard,et al. Development of a cold storage solution for pancreas preservation. , 1986, Cryobiology.
[193] A. Novick,et al. DETRIMENTAL EFFECT OF CYCLOSPORINE ON INITIAL FUNCTION OF CADAVER RENAL ALLOGRAFTS FOLLOWING EXTENDED PRESERVATION Results of a randomized Prospective Study , 1986, Transplantation.
[194] P. W. Hochachka. Defense strategies against hypoxia and hypothermia. , 1986, Science.
[195] Lond Mb. Frederick Ronald Chistopher Casson. , 1975 .
[196] P. Terasaki,et al. Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. , 1970, Lancet.
[197] M. Kowada,et al. Cerebral ischemia. II. The no-reflow phenomenon. , 1968, The American journal of pathology.